Recently, it has become clear that inter-organ communication by way of the autonomic nervous system is necessary to maintain the highly organized orchestra of metabolic and cardiovascular systems [@bib0005].

One such case is the renal sympathetic nerves, which have been identified as a major contributor to the complex pathophysiology of hypertension. Patients with essential hypertension have increased efferent sympathetic drive to the kidneys and increased rate of sympathetic-nerve firing modulated by afferent signaling from renal sensory nerves [@bib0010], [@bib0015], [@bib0020]. Thus, the renal nerve ablation (RNA) technique using a radiofrequency (RF) catheter has been developed to cure severe, drug-resistant, hypertension. This procedure resulted in a 42% decrease in whole-body norepinephrine spillover and a substantial reduction in blood pressure and sustained normalization of sympathetic-nerve firing rates with a reduction in left ventricular mass during the follow-up period [@bib0025], [@bib0030], [@bib0035].

Despite initial studies showing the safety and efficacy of this procedure, recent clinical studies suggested the possibility of vascular impairments after catheter-based intervention. Templin et al. evaluated morphological features before and after RNA by optical coherence tomography (OCT) [@bib0040]. OCT has been established as an intracoronary imaging tool for visualizing stent apposition and healing, plaque characterization, thrombus formation, and dissection with a high spatial resolution of 10--15 μm. Thanks to its high resolution, OCT is able to detect local vascular injuries that are angiographically undetectable. They observed diffuse renal artery constriction and local tissue damage at the ablation site with edema and thrombus formation after RNA. Similar findings were also obtained in a porcine model of RNA, and acute loss of endothelialization resulted in thrombus formation [@bib0045]. These findings suggest that antiplatelet therapy is definitely required during RNA.

Angioscopy is an endoscopic technique that allows direct visualization of the internal surface of a vessel and provides information regarding plaque morphology and the thrombus in detail in patients with a high resolution (10--50 μm). Ulcerlation, fissures, and tears on plaques can be observed and clearly demarcated from the adjacent vessel wall. There have been many reports about angioscopy of coronary arteries. A normal coronary artery appears as glistening white, whereas atherosclerotic plaque can be categorized as yellow-white. The intensity of the yellow color is also an indicator of fibrous cap thickness, with high yellow intensity associated with thin, fibrous caps overlaying a lipid core. The yellow intensity of the plaque can be classified semiquantitatively [@bib0050], [@bib0055], [@bib0060].

In their report, Komatsu et al. analyzed atherosclerosis in a renal artery by several modalities [@bib0065]. Computed tomography, renal angiography, and intravascular ultrasound also revealed the existence of a lipid-rich component and fibrous to calcified components in the stenotic region. They observed the plaque by angioscopy after percutaneous transluminal renal angioscopy and found one grade 3 yellow plaque at the proximal end of the stent and grade 1 and 2 plaques in the middle and distal portions of the artery. They discussed the potential implications of angioscopy to evaluate vascular injuries after RNA.

There are several limitations to angioscopy. First, it observes only the surface of the arterial lumen. Second, it is impossible to evaluate angioscopic findings fully quantitatively. Thus, methods of image quantification, such as quantitative colorimetric analysis, have been developed to overcome the limitations inherent in angioscopic images. However, angioscopic analysis has the advantage to detect the thrombus more sensitively than other imaging modalities and it may offer the opportunity for observations by angioscopy after RNA.

It may be necessary to reduce radiofrequency energy levels during RNA to reduce vascular injury. Currently, we cannot select ablation sites during RNA. However, if we can select and ablate only at the healthy vascular lumen without the plaque, it may be possible to reduce the radiofrequency energy. Multi-modalities for vascular imaging including angioscopy may be used for this purpose in the future.
